254 related articles for article (PubMed ID: 15983551)
1. A phase Ib clinical trial of PV701, a milk-derived protein extract, for the prevention and treatment of oral mucositis in patients undergoing high-dose BEAM chemotherapy.
Prince HM; Regester G; Gates P; Jablonskis L; Seymour JF; Lillie K; West R; Wolf M; Januszewicz H; Belford D
Biol Blood Marrow Transplant; 2005 Jul; 11(7):512-20. PubMed ID: 15983551
[TBL] [Abstract][Full Text] [Related]
2. The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT.
McCann S; Schwenkglenks M; Bacon P; Einsele H; D'Addio A; Maertens J; Niederwieser D; Rabitsch W; Roosaar A; Ruutu T; Schouten H; Stone R; Vorkurka S; Quinn B; Blijlevens N;
Bone Marrow Transplant; 2009 Jan; 43(2):141-7. PubMed ID: 18776926
[TBL] [Abstract][Full Text] [Related]
3. High-dose CEB vs BEAM with autologous stem cell transplant in lymphoma.
Wang EH; Chen YA; Corringham S; Bashey A; Holman P; Ball ED; Carrier E
Bone Marrow Transplant; 2004 Oct; 34(7):581-7. PubMed ID: 15273714
[TBL] [Abstract][Full Text] [Related]
4. Efficiency of supersaturated calcium phosphate mouth rinse treatment in patients receiving high-dose melphalan or BEAM prior to autologous blood stem cell transplantation: a single-center experience.
Waśko-Grabowska A; Rzepecki P; Oborska S; Barzał J; Gawroński K; Młot B; Szczylik C
Transplant Proc; 2011 Oct; 43(8):3111-3. PubMed ID: 21996239
[TBL] [Abstract][Full Text] [Related]
5. Treatment of oral mucositis after peripheral blood SCT with ATL-104 mouthwash: results from a randomized, double-blind, placebo-controlled trial.
Hunter A; Mahendra P; Wilson K; Fields P; Cook G; Peniket A; Crawley C; Hickling R; Marcus R
Bone Marrow Transplant; 2009 Apr; 43(7):563-9. PubMed ID: 18997832
[TBL] [Abstract][Full Text] [Related]
6. Neutropenic infections in 100 patients with non-Hodgkin's lymphoma or Hodgkin's disease treated with high-dose BEAM chemotherapy and peripheral blood progenitor cell transplant: out-patient treatment is a viable option.
Seropian S; Nadkarni R; Jillella AP; Salloum E; Burtness B; Hu GL; Zelterman D; Cooper DL
Bone Marrow Transplant; 1999 Mar; 23(6):599-605. PubMed ID: 10217191
[TBL] [Abstract][Full Text] [Related]
7. Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group.
Blijlevens N; Schwenkglenks M; Bacon P; D'Addio A; Einsele H; Maertens J; Niederwieser D; Rabitsch W; Roosaar A; Ruutu T; Schouten H; Stone R; Vokurka S; Quinn B; McCann S;
J Clin Oncol; 2008 Mar; 26(9):1519-25. PubMed ID: 18268357
[TBL] [Abstract][Full Text] [Related]
8. The risk factors for oral mucositis and the effect of cryotherapy in patients after the BEAM and HD-l-PAM 200 mg/m(2) autologous hematopoietic stem cell transplantation.
Vokurka S; Bystricka E; Scudlova J; Mazur E; Visokaiova M; Vasilieva E; Brandejsova R; Chvojkova I; Vrabcova M; Vitkova J; Mjartanova D; Vodickova M; Bockova J; Streinerova K
Eur J Oncol Nurs; 2011 Dec; 15(5):508-12. PubMed ID: 21310656
[TBL] [Abstract][Full Text] [Related]
9. Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphoma.
Costa LJ; Micallef IN; Inwards DJ; Johnston PB; Porrata LF; Litzow MR; Ansell SM
Br J Haematol; 2008 Oct; 143(2):268-73. PubMed ID: 18699848
[TBL] [Abstract][Full Text] [Related]
10. Comorbidities, not age, impact outcomes in autologous stem cell transplant for relapsed non-Hodgkin lymphoma.
Wildes TM; Augustin KM; Sempek D; Zhang QJ; Vij R; Dipersio JF; Devine SM
Biol Blood Marrow Transplant; 2008 Jul; 14(7):840-6. PubMed ID: 18541205
[TBL] [Abstract][Full Text] [Related]
11. Keratinocyte growth factor is effective in the prevention of intestinal mucositis in patients with hematological malignancies treated with high-dose chemotherapy and autologous hematopoietic SCT: a video-capsule endoscopy study.
Tsirigotis P; Triantafyllou K; Girkas K; Giannopoulou V; Ioannidou E; Chondropoulos S; Kalli T; Papaxoinis G; Pappa V; Papageorgiou E; Economopoulos T; Ladas SD; Dervenoulas J
Bone Marrow Transplant; 2008 Sep; 42(5):337-43. PubMed ID: 18560408
[TBL] [Abstract][Full Text] [Related]
12. Oral mucositis and outcomes of autologous hematopoietic stem-cell transplantation following high-dose melphalan conditioning for multiple myeloma.
Vera-Llonch M; Oster G; Ford CM; Lu J; Sonis S
J Support Oncol; 2007 May; 5(5):231-5. PubMed ID: 17564153
[TBL] [Abstract][Full Text] [Related]
13. BEAC or BEAM high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma patients: comparative analysis of efficacy and toxicity.
Jo JC; Kang BW; Jang G; Sym SJ; Lee SS; Koo JE; Kim JW; Kim S; Huh J; Suh C
Ann Hematol; 2008 Jan; 87(1):43-8. PubMed ID: 17710401
[TBL] [Abstract][Full Text] [Related]
14. Colchicine mouth washings to improve oral mucositis in patients with hematological malignancies: a clinical trial.
Garavito AA; Cardona AF; Reveiz L; Ospina E; Yepes A; Ospina V
Palliat Support Care; 2008 Dec; 6(4):371-6. PubMed ID: 19006592
[TBL] [Abstract][Full Text] [Related]
15. [Transdermal fentanyl in treating severe painful mucositis caused by autologous hematopoietic stem cell transplantation].
Huang HQ; Cai QQ; Lin XB; Wang BF; Bu Q; Gao Y; Peng YL
Ai Zheng; 2007 Apr; 26(4):390-3. PubMed ID: 17430658
[TBL] [Abstract][Full Text] [Related]
16. Ifosfamide, epirubicin, etoposide (IEV) and autologous peripheral blood progenitor cell transplant: a feasible and effective salvage treatment for lymphoid malignancies.
Clavio M; Garrone A; Pierri I; Michelis GL; Balocco M; Albarello A; Varaldo R; Canepa P; Miglino M; Ballerini F; Canepa L; Gobbi M
Oncol Rep; 2005 Oct; 14(4):933-40. PubMed ID: 16142354
[TBL] [Abstract][Full Text] [Related]
17. Phase I/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic stem cell transplantation.
Freytes CO; Ratanatharathorn V; Taylor C; Abboud C; Chesser N; Restrepo A; Arango J; Odenheimer D
Clin Cancer Res; 2004 Dec; 10(24):8318-24. PubMed ID: 15623608
[TBL] [Abstract][Full Text] [Related]
18. [Autologous transplant with BEAM protocol in lymphoma].
Caballero D; Rubio V; Rifon J; Heras I; García-Sanz R; Vidriales B; Pérez-Simón JA; del Cañizo C; González M; León A; Jean-Paul E; Rocha E; Vicente V; San Miguel JF
Sangre (Barc); 1997 Apr; 42 Suppl 1():46-9. PubMed ID: 9381303
[No Abstract] [Full Text] [Related]
19. Phase I study of transforming growth factor-beta3 mouthwashes for prevention of chemotherapy-induced mucositis.
Wymenga AN; van der Graaf WT; Hofstra LS; Spijkervet FK; Timens W; Timmer-Bosscha H; Sluiter WJ; van Buuren AH; Mulder NH; de Vries EG
Clin Cancer Res; 1999 Jun; 5(6):1363-8. PubMed ID: 10389920
[TBL] [Abstract][Full Text] [Related]
20. Propantheline protects the oral mucosa after high-dose ifosfamide, carboplatin, etoposide and autologous stem cell transplantation.
Oblon DJ; Paul SR; Oblon MB; Malik S
Bone Marrow Transplant; 1997 Dec; 20(11):961-3. PubMed ID: 9422475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]